This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Neahring, J. M. Articles by Egan, B. M. Search for Related Content PubMed PubMed Citation Articles by Neahring, J. M. Articles by Egan, B. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Obesity

Hypertension, Vol 22, 584-590, Copyright © 1993 by American Heart Association

ARTICLES

Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men

JM Neahring, K Stepniakowski, AS Greene and BM Egan
Division of Cardiology-Hypertension, Medical College of Wisconsin, Milwaukee.

Evidence supports the hypothesis that an impaired capacity of insulin to antagonize norepinephrine-induced vasoconstriction increases alpha- adrenergic tone in overweight young men with insulin resistance and mild hypertension. Therefore, the effects of regionally infused insulin at 100 microU/mL on forearm blood flow (milliliters per deciliter per minute) and responses to norepinephrine were measured in seven obese hypertensive and eight lean normotensive men younger than 45 years old. The obese hypertensive men were hyperinsulinemic and insulin resistant compared with the normotensive men, as evidenced by abnormal values for fasting insulin (15.5 +/- 1.6 versus 7.2 +/- 0.8 microU/mL, P < .001), the insulin area under the curve in response to a 2-hour oral glucose tolerance test (12.0 +/- 1.5 versus 6.7 +/- 1.1 mU x min/dL, P < .01), and the disappearance rate of glucose during a 15-minute insulin tolerance test (2.7 +/- 0.3 versus 4.1 +/- 0.3 mg%/min, P < .05). The logarithm of the norepinephrine EC50 was not significantly different in obese hypertensive men (mean, 95% confidence interval: -8.15, -8.42 to - 7.87) versus lean normotensive men (-7.91, -8.23 to -7.59). The 2-hour regional insulin infusion at 100 microU/mL did not significantly alter the EC50 for norepinephrine in either group. Insulin at this concentration induced significant and similar increases of forearm blood flow in the hypertensive and normotensive groups (1.7 +/- 0.4 versus 1.7 +/- 0.6 mL/100 mL per minute, P = NS). At approximately 100 microU/mL, insulin does not antagonize norepinephrine-induced vasoconstriction in the forearm circulation of either obese hypertensive or lean normotensive men.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. V. Agapitov, M. L. d. G. Correia, C. A. Sinkey, and W. G. Haynes Dissociation Between Sympathetic Nerve Traffic and Sympathetically Mediated Vascular Tone in Normotensive Human Obesity Hypertension, October 1, 2008; 52(4): 687 - 695. [Abstract] [Full Text] [PDF]

				R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF]

				M. G. Clark, M. G. Wallis, E. J. Barrett, M. A. Vincent, S. M. Richards, L. H. Clerk, and S. Rattigan Blood flow and muscle metabolism: a focus on insulin action Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E241 - E258. [Abstract] [Full Text] [PDF]

				S. J. Cleland, J. R. Petrie, S. Ueda, H. L. Elliott, and J. M. C. Connell Insulin-Mediated Vasodilation and Glucose Uptake Are Functionally Linked in Humans Hypertension, January 1, 1999; 33(1): 554 - 558. [Abstract] [Full Text] [PDF]

				S. Ueda, J. R. Petrie, S. J. Cleland, H. L. Elliott, and J. M. C. Connell The Vasodilating Effect of Insulin Is Dependent on Local Glucose Uptake: A Double Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2126 - 2131. [Abstract] [Full Text]

				U. Scherrer and C. Sartori Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity Circulation, December 2, 1997; 96(11): 4104 - 4113. [Abstract] [Full Text]

				K. T. Stepniakowski, G. Lu, G. D. Miller, and B. M. Egan Fatty Acids, Not Insulin, Modulate {alpha}1-Adrenergic Reactivity in Dorsal Hand Veins Hypertension, November 1, 1997; 30(5): 1150 - 1155. [Abstract] [Full Text]

				M. M.I. Hennes, I. M. O'Shaughnessy, T. M. Kelly, P. LaBelle, B. M. Egan, and A. H. Kissebah Insulin-Resistant Lipolysis in Abdominally Obese Hypertensive Individuals: Role of the Renin-Angiotensin System Hypertension, July 1, 1996; 28(1): 120 - 126. [Abstract] [Full Text]

				B. M. Egan, M. M.I. Hennes, K. T. Stepniakowski, I. M. O'Shaughnessy, A. H. Kissebah, and T. L. Goodfriend Obesity Hypertension Is Related More to Insulin's Fatty Acid Than Glucose Action Hypertension, March 1, 1996; 27(3): 723 - 728. [Abstract] [Full Text]

				S. Taddei, A. Virdis, P. Mattei, A. Natali, E. Ferrannini, and A. Salvetti Effect of Insulin on Acetylcholine-Induced Vasodilation in Normotensive Subjects and Patients With Essential Hypertension Circulation, November 15, 1995; 92(10): 2911 - 2918. [Abstract] [Full Text]

				R. K. Davda, K. T. Stepniakowski, G. Lu, M. E. Ullian, T. L. Goodfriend, and B. M. Egan Oleic Acid Inhibits Endothelial Nitric Oxide Synthase by a Protein Kinase C-Independent Mechanism Hypertension, November 1, 1995; 26(5): 764 - 770. [Abstract] [Full Text]

				I. M. O'Shaughnessy, T. J. Myers, K. Stepniakowski, P. Nazzaro, T. M. Kelly, R. G. Hoffmann, B. M. Egan, and A. H. Kissebah Glucose Metabolism in Abdominally Obese Hypertensive and Normotensive Subjects Hypertension, July 1, 1995; 26(1): 186 - 192. [Abstract] [Full Text]

				K. T. Stepniakowski, T. L. Goodfriend, and B. M. Egan Fatty Acids Enhance Vascular {alpha}-Adrenergic Sensitivity Hypertension, April 1, 1995; 25(4): 774 - 778. [Abstract] [Full Text]

				T. L. Goodfriend, B. Egan, K. Stepniakowski, and D. L. Ball Relationships Among Plasma Aldosterone, High-Density Lipoprotein Cholesterol, and Insulin in Humans Hypertension, January 1, 1995; 25(1): 30 - 36. [Abstract] [Full Text]